ERBB2 and breast carcinoma: Additionally, the presence of Apt increased the cytoplasmic uptake and cytotoxicity of the NPs in HER2-overexpressing SK-BR-3 cells, indicating that the Apt-CUR-HSA-NPs may be a promising treatment for HER2-positive breast cancer.